Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 97

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development

Marchetti, Marialaura, De Bei, Omar, Bettati, Stefano, Campanini, Barbara, Kovachka, Sandra, Gianquinto, Eleonora, Spyrakis, Francesca, Ronda, Luca · 2020 · International Journal of Molecular Sciences

Abstract

Nutritional immunity is a form of innate immunity widespread in both vertebrates and invertebrates. The term refers to a rich repertoire of mechanisms set up by the host to inhibit bacterial proliferation by sequestering trace minerals (mainly iron, but also zinc and manganese). This strategy, selected by evolution, represents an effective front-line defense against pathogens and has thus inspired the exploitation of iron restriction in the development of innovative antimicrobials or enhancers of antimicrobial therapy. This review focuses on the mechanisms of nutritional immunity, the strategies adopted by opportunistic human pathogen Staphylococcus aureus to circumvent it, and the impact of deletion mutants on the fitness, infectivity, and persistence inside the host. This information finally converges in an overview of the current development of inhibitors targeting the different stages of iron uptake, an as-yet unexploited target in the field of antistaphylococcal drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21062145

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 95 references

Research works printed but not linked: 232

  1. Perutz, 1970, Stereochemistry of cooperative effects in haemoglobin: Haem–haem interaction and the problem of allostery, Nature, 228, 726, 10.1038/228726a0 · DOI · Paper page
  2. Sabio, 2017, Iron chemistry at the service of life, IUBMB Life, 69, 382, 10.1002/iub.1602 · DOI · Paper page
  3. Golonka, 2019, The iron tug-of-war between bacterial siderophores and innate immunity, J. Innate Immun., 11, 249, 10.1159/000494627 · DOI · Paper page
  4. Bullen, 1978, Role of iron in bacterial infection, Curr. Top. Microbiol. Immunol., 80, 1
  5. Weinberg, 1975, Nutritional immunity, JAMA, 231, 39, 10.1001/jama.1975.03240130021018 · DOI · Paper page
  6. Jamroz, 1993, Transferrin in a cockroach: Molecular cloning, characterization, and suppression by juvenile hormone, Proc. Natl. Acad. Sci. USA, 90, 1320, 10.1073/pnas.90.4.1320 · DOI
  7. Medzhitov, 1997, Innate immunity: Impact on the adaptive immune response, Curr. Opin. Immunol., 9, 4, 10.1016/S0952-7915(97)80152-5 · DOI · Paper page
  8. Wright, 1991, Multiple receptors for endotoxin, Curr. Opin. Immunol., 3, 83, 10.1016/0952-7915(91)90082-C · DOI · Paper page
  9. Gruenheid, 1999, Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron, Blood, 93, 4406, 10.1182/blood.V93.12.4406 · DOI · Paper page
  10. Sun, 1999, Transferrin as a metal ion mediator, Chem. Rev., 99, 2817, 10.1021/cr980430w · DOI · Paper page
  11. Wally, 2006, The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding, J. Biol. Chem., 281, 24934, 10.1074/jbc.M604592200 · DOI · Paper page
  12. Yang, 2012, Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe, Sci. Rep., 2, 999, 10.1038/srep00999 · DOI
  13. Ammons, 2013, Mini-review: Lactoferrin: A bioinspired, anti-biofilm therapeutic, Biofouling, 29, 443, 10.1080/08927014.2013.773317 · DOI
  14. Langlois, 2004, Haptoglobin polymorphisms and iron homeostasis in health and in disease, Clin. Chim. Acta, 345, 35, 10.1016/j.cccn.2004.03.016 · DOI
  15. Delanghe, 2000, Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography, Clin. Chim. Acta, 291, 43, 10.1016/S0009-8981(99)00194-1 · doi:10.1016/s0009-8981(99)00194-1
  16. Cahill, 2010, Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency, Am. J. Clin. Nutr., 92, 1494, 10.3945/ajcn.2010.29306 · DOI
  17. Ward, 2007, Hepcidin regulation: Ironing out the details, J. Clin. Investig., 117, 1755, 10.1172/JCI32701 · DOI · Paper page
  18. Wilson, 2006, Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis, Biochem. Biophys. Res. Commun., 348, 320, 10.1016/j.bbrc.2006.07.055 · DOI · Paper page
  19. DePalma, 2007, Bloodletting: Past and present, J. Am. Coll. Surg., 205, 132, 10.1016/j.jamcollsurg.2007.01.071 · DOI
  20. Haddock, 1991, Infant diet and salmonellosis, Am. J. Public Health, 81, 997, 10.2105/AJPH.81.8.997 · DOI
  21. Bilitewski, 2017, Chemical and biological aspects of nutritional immunity-perspectives for new anti-infectives that target iron uptake systems, Angew. Chemie Int. Ed., 56, 14360, 10.1002/anie.201701586 · DOI
  22. Endicott, 2017, Structural basis for xenosiderophore utilization by the human pathogen Staphylococcus aureus, ACS Infect. Dis., 3, 542, 10.1021/acsinfecdis.7b00036 · DOI
  23. Deane, 2016, Metal-pilfering pathogens, Nat. Chem. Biol., 12, 575, 10.1038/nchembio.2139 · DOI
  24. Cheng, 2011, A play in four acts: Staphylococcus aureus abscess formation, Trends Microbiol., 19, 225, 10.1016/j.tim.2011.01.007 · DOI · Paper page
  25. Cassat, 2018, Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions, Sci. Transl. Med., 10, eaan6361, 10.1126/scitranslmed.aan6361 · DOI · Paper page
  26. Sheldon, 2012, The iron-regulated staphylococcal lipoproteins, Front. Cell. Infect. Microbiol., 2, 41, 10.3389/fcimb.2012.00041 · DOI
  27. Grigg, 2010, The Staphylococcus aureus siderophore receptor HtsA undergoes localized conformational changes to enclose staphyloferrin A in an arginine-rich binding pocket, J. Biol. Chem., 285, 11162, 10.1074/jbc.M109.097865 · DOI
  28. Kobylarz, 2016, Deciphering the substrate specificity of SbnA, the enzyme catalyzing the first step in staphyloferrin B biosynthesis, Biochemistry, 55, 927, 10.1021/acs.biochem.5b01045 · DOI
  29. Kobylarz, 2014, Synthesis of L-2,3-diaminopropionic acid, a siderophore and antibiotic precursor, Chem. Biol., 21, 379, 10.1016/j.chembiol.2013.12.011 · DOI
  30. Kobylarz, 2014, SbnG, a citrate synthase in Staphylococcus aureus, J. Biol. Chem., 289, 33797, 10.1074/jbc.M114.603175 · DOI
  31. Verstraete, 2018, SbnI is a free serine kinase that generates O -phospho-l-serine for staphyloferrin B biosynthesis in Staphylococcus aureus, J. Biol. Chem., 293, 6147, 10.1074/jbc.RA118.001875 · DOI
  32. Tang, 2019, Structural insights into substrate recognition and activity regulation of the key decarboxylase SbnH in staphyloferrin B biosynthesis, J. Mol. Biol., 431, 4868, 10.1016/j.jmb.2019.10.009 · DOI
  33. Podkowa, 2014, Crystal and solution structure analysis of FhuD2 from Staphylococcus aureus in multiple unliganded conformations and bound to ferrioxamine-B, Biochemistry, 53, 2017, 10.1021/bi401349d · DOI
  34. Mariotti, 2013, Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2, Biochem. J., 449, 683, 10.1042/BJ20121426 · DOI
  35. Kobylarz, 2017, Iron uptake oxidoreductase (IruO) uses a flavin adenine dinucleotide semiquinone intermediate for iron-siderophore reduction, ACS Chem. Biol., 12, 1778, 10.1021/acschembio.7b00203 · DOI
  36. Song, 1996, Structure of Staphylococcal alpha-hemolysin, a heptameric transmembrane pore, Science, 274, 1859, 10.1126/science.274.5294.1859 · DOI · Paper page
  37. Yamashita, 2011, Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components, Proc. Natl. Acad. Sci. USA, 108, 17314, 10.1073/pnas.1110402108 · DOI · Paper page
  38. Nocadello, 2016, Crystal structures of the components of the Staphylococcus aureus leukotoxin ED, Acta Crystallogr. Sect. D Struct. Biol., 72, 113, 10.1107/S2059798315023207 · DOI
  39. Zong, 2004, Crystal structures of Staphylococcus aureus sortase A and its substrate complex, J. Biol. Chem., 279, 31383, 10.1074/jbc.M401374200 · DOI · Paper page
  40. Zhang, 2004, Structures of sortase B from Staphylococcus aureus and Bacillus anthracis reveal catalytic amino acid triad in the active site, Structure, 12, 1147, 10.1016/j.str.2004.06.001 · DOI
  41. Jacobitz, 2014, Structural and computational studies of the Staphylococcus aureus sortase B-substrate complex reveal a substrate-stabilized oxyanion hole, J. Biol. Chem., 289, 8891, 10.1074/jbc.M113.509273 · DOI
  42. Dickson, 2015, The structure of haemoglobin bound to the haemoglobin receptor IsdH from Staphylococcus aureus shows disruption of the native α-globin haem pocket, Acta Crystallogr. Sect. D Biol. Crystallogr., 71, 1295, 10.1107/S1399004715005817 · DOI
  43. Bowden, 2018, Structure–function analyses reveal key features in Staphylococcus aureus IsdB-associated unfolding of the heme-binding pocket of human hemoglobin, J. Biol. Chem., 293, 177, 10.1074/jbc.M117.806562 · DOI
  44. Grigg, 2007, Heme coordination by Staphylococcus aureus IsdE, J. Biol. Chem., 282, 28815, 10.1074/jbc.M704602200 · DOI · Paper page
  45. Challis, 2005, A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases, ChemBioChem, 6, 601, 10.1002/cbic.200400283 · DOI · Paper page
  46. Collins, 1962, The effect of growth conditions on oxidative and dehydrogenase activity in Staphylococcus aureus, J. Gen. Microbiol., 29, 531, 10.1099/00221287-29-3-531 · DOI
  47. Hannauer, 2015, Involvement of major facilitator superfamily proteins SfaA and SbnD in staphyloferrin secretion in Staphylococcus aureus, FEBS Lett., 589, 730, 10.1016/j.febslet.2015.02.002 · DOI
  48. Nakaminami, 2017, Efflux transporter of siderophore staphyloferrin A in Staphylococcus aureus contributes to bacterial fitness in abscesses and epithelial cells, Infect. Immun., 85, 1, 10.1128/IAI.00358-17 · DOI
  49. Madsen, 2015, Chemical synthesis of staphyloferrin B affords insight into the molecular structure, iron chelation, and biological activity of a polycarboxylate siderophore deployed by the human pathogen Staphylococcus aureus, J. Am. Chem. Soc., 137, 9117, 10.1021/jacs.5b04557 · DOI
  50. Beasley, F.C., Cheung, J., and Heinrichs, D.E. (2011). Mutation of L-2,3-diaminopropionic acid synthase genes blocks staphyloferrin B synthesis in Staphylococcus aureus. BMC Microbiol., 11. · DOI
  51. Dale, 2004, Involvement of SirABC in iron-siderophore import in Staphylococcus aureus, J. Bacteriol., 186, 8356, 10.1128/JB.186.24.8356-8362.2004 · DOI · Paper page
  52. Heinrichs, 1999, Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus, J. Bacteriol., 181, 1436, 10.1128/JB.181.5.1436-1443.1999 · DOI
  53. Hannauer, 2015, Involvement of reductases IruO and NtrA in iron acquisition by Staphylococcus aureus, Mol. Microbiol., 96, 1192, 10.1111/mmi.13000 · DOI
  54. Courcol, 1997, Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins, Infect. Immun., 65, 1944, 10.1128/iai.65.5.1944-1948.1997 · DOI · Paper page
  55. Fojcik, 2018, Independent and cooperative regulation of staphylopine biosynthesis and trafficking by Fur and Zur, Mol. Microbiol., 108, 159, 10.1111/mmi.13927 · DOI
  56. Song, 2018, Mechanistic insights into staphylopine-mediated metal acquisition, Proc. Natl. Acad. Sci. USA, 115, 3942, 10.1073/pnas.1718382115 · DOI
  57. Chen, 2019, Intracellular accumulation of staphylopine impairs the fitness of Staphylococcus aureus cntE mutant, FEBS Lett., 593, 1213, 10.1002/1873-3468.13396 · DOI
  58. Neumann, 2017, Metal homeostasis in infectious disease: Recent advances in bacterial metallophores and the human metal-withholding response, Curr. Opin. Chem. Biol., 37, 10, 10.1016/j.cbpa.2016.09.012 · DOI
  59. Brock, 1983, The effect of desferrioxamine on the growth of Staphylococcus aureus, Yersinia enterocolitica and Streptococcus faecalis in human serum: Uptake of desferrioxamine-bound iron, FEMS Microbiol. Lett., 20, 439, 10.1111/j.1574-6968.1983.tb00164.x · DOI · Paper page
  60. Sebulsky, 2003, The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus, J. Biol. Chem., 278, 49890, 10.1074/jbc.M305073200 · DOI
  61. Mishra, 2012, Staphylococcus aureus FhuD2 Is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice, J. Infect. Dis., 206, 1041, 10.1093/infdis/jis463 · DOI
  62. Sebulsky, 2001, Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus, J. Bacteriol., 183, 4994, 10.1128/JB.183.17.4994-5000.2001 · DOI
  63. Morrissey, 2000, Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus, Infect. Immun., 68, 6281, 10.1128/IAI.68.11.6281-6288.2000 · DOI · Paper page
  64. Miethke, 2006, Ferri-bacillibactin uptake and hydrolysis in Bacillus subtilis, Mol. Microbiol., 61, 1413, 10.1111/j.1365-2958.2006.05321.x · DOI · Paper page
  65. Abergel, 2009, Enzymatic hydrolysis of trilactone siderophores: Where chiral recognition occurs in enterobactin and bacillibactin iron transport, J. Am. Chem. Soc., 131, 12682, 10.1021/ja903051q · DOI
  66. Lin, 2005, In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes, J. Am. Chem. Soc., 127, 11075, 10.1021/ja0522027 · DOI · Paper page
  67. Cheung, 1994, Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus, J. Bacteriol., 176, 580, 10.1128/jb.176.3.580-585.1994 · DOI
  68. Novick, 2003, Autoinduction and signal transduction in the regulation of staphylococcal virulence, Mol. Microbiol., 48, 1429, 10.1046/j.1365-2958.2003.03526.x · DOI · Paper page
  69. Venkatasubramaniam, A., Kanipakala, T., Ganjbaksh, N., Mehr, R., Mukherjee, I., Krishnan, S., Bae, T., Aman, M.J., and Adhikari, R.P. (2018). A critical role for HlgA in Staphylococcus aureus pathogenesis revealed by a switch in the SaeRS two-component regulatory system. Toxins (Basel)., 10. · DOI
  70. Bhakdil, 1991, Alpha-toxin of Staphylococcus aureus, Microbiol. Rev., 55, 733, 10.1128/mr.55.4.733-751.1991 · doi:10.1128/mr.55.4.733-751.1991 · Paper page
  71. Nilsson, 1999, Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis, Infect. Immun., 67, 1045, 10.1128/IAI.67.3.1045-1049.1999 · DOI
  72. Wardenburg, 2007, Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia, Infect. Immun., 75, 1040, 10.1128/IAI.01313-06 · DOI · Paper page
  73. Kielian, 2001, Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses, Infect. Immun., 69, 6902, 10.1128/IAI.69.11.6902-6911.2001 · DOI
  74. Malachowa, N., Whitney, A.R., Kobayashi, S.D., Sturdevant, D.E., Kennedy, A.D., Braughton, K.R., Shabb, D.W., Diep, B.A., Chambers, H.F., and Otto, M. (2011). Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE, 6. · DOI · Paper page
  75. Yoong, 2015, Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence, Nat. Commun., 6, 8125, 10.1038/ncomms9125 · DOI
  76. Fraunholz, 2012, Intracellular staphylococcus aureus: Live-in and let die, Front. Cell. Infect. Microbiol., 2, 43, 10.3389/fcimb.2012.00043 · DOI · Paper page
  77. Strobel, 2016, Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain, Clin. Microbiol. Infect., 22, 799, 10.1016/j.cmi.2016.06.020 · DOI · Paper page
  78. McCarthy, 2013, Staphylococcus aureus innate immune evasion is lineage-specific: A bioinfomatics study, Infect. Genet. Evol., 19, 7, 10.1016/j.meegid.2013.06.012 · DOI
  79. Schneewind, 1995, Structure of the cell wall anchor of surface proteins in Staphylococcus aureus, Science, 268, 103, 10.1126/science.7701329 · DOI · Paper page
  80. Taylor, 2002, Transferrin binding in Staphylococcus aureus: Involvement of a cell wall-anchored protein, Mol. Microbiol., 43, 1603, 10.1046/j.1365-2958.2002.02850.x · DOI
  81. Clarke, 2004, IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin, Mol. Microbiol., 51, 1509, 10.1111/j.1365-2958.2003.03938.x · DOI · Paper page
  82. Abe, 2012, Mapping ultra-weak protein-protein interactions between heme transporters of Staphylococcus aureus, J. Biol. Chem., 287, 16477, 10.1074/jbc.M112.346700 · DOI
  83. Tiedemann, 2012, Multiprotein heme shuttle pathway in Staphylococcus aureus: Iron-regulated surface determinant cog-wheel kinetics, J. Am. Chem. Soc., 134, 16578, 10.1021/ja305115y · DOI
  84. Takayama, 2011, Electronic properties of the highly ruffled heme bound to the heme degrading enzyme IsdI, Proc. Natl. Acad. Sci. USA, 108, 13071, 10.1073/pnas.1101459108 · DOI
  85. Reniere, 2008, Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem, Mol. Microbiol., 69, 1304, 10.1111/j.1365-2958.2008.06363.x · DOI · Paper page
  86. Verstraete, 2019, The heme-sensitive regulator SbnI has a bifunctional role in staphyloferrin B production by Staphylococcus aureus, J. Biol. Chem., 294, 11622, 10.1074/jbc.RA119.007757 · DOI
  87. Loutet, 2013, IruO is a reductase for heme degradation by IsdI and IsdG proteins in Staphylococcus aureus, J. Biol. Chem., 288, 25749, 10.1074/jbc.M113.470518 · DOI
  88. Foster, 2014, Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  89. Clarke, 2008, IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin, Infect. Immun., 76, 1518, 10.1128/IAI.01530-07 · DOI · Paper page
  90. Speziale, 2014, Protein-based biofilm matrices in Staphylococci, Front. Cell. Infect. Microbiol., 4, 1, 10.3389/fcimb.2014.00171 · DOI · Paper page
  91. Missineo, 2014, IsdC from Staphylococcus lugdunensis induces biofilm formation under low-iron growth conditions, Infect. Immun., 82, 2448, 10.1128/IAI.01542-14 · DOI
  92. Miajlovic, 2010, Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets, Microbiology, 156, 920, 10.1099/mic.0.036673-0 · DOI
  93. Zapotoczna, 2013, Iron-regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non-phagocytic human cells, Cell. Microbiol., 15, 1026, 10.1111/cmi.12097 · DOI
  94. Biswas, 2009, Role of the twin-arginine translocation pathway in Staphylococcus, J. Bacteriol., 191, 5921, 10.1128/JB.00642-09 · DOI
  95. Turlin, E., Débarbouillé, M., Augustyniak, K., Gilles, A.-M., and Wandersman, C. (2013). Staphylococcus aureus FepA and FepB proteins drive heme iron utilization in Escherichia coli. PLoS ONE, 8. · DOI
  96. Heuck, 2009, Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact, Proc. Natl. Acad. Sci. USA, 106, 11719, 10.1073/pnas.0903842106 · DOI
  97. Reniere, 2007, Intracellular metalloporphyrin metabolism in Staphylococcus aureus, BioMetals, 20, 333, 10.1007/s10534-006-9032-0 · DOI · Paper page
  98. Tiburzi, 2009, Is the host heme incorporated in microbial heme-proteins?, IUBMB Life, 61, 80, 10.1002/iub.123 · DOI
  99. Bernhardt, 2016, Costs of life - dynamics of the protein inventory of Staphylococcus aureus during anaerobiosis, Sci. Rep., 6, 28172, 10.1038/srep28172 · DOI
  100. Nobre, 2013, Effect of combined oxidative and nitrosative stresses on Staphylococcus aureus transcriptome, Appl. Microbiol. Biotechnol., 97, 2563, 10.1007/s00253-013-4730-3 · DOI
  101. Mazmanian, 2000, Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections, Proc. Natl. Acad. Sci. USA, 97, 5510, 10.1073/pnas.080520697 · DOI · Paper page
  102. Chen, 2014, Role of sortase A in the pathogenesis of Staphylococcus aureus-induced mastitis in mice, FEMS Microbiol. Lett., 351, 95, 10.1111/1574-6968.12354 · DOI
  103. Jonsson, 2003, The role of Staphylococcus aureus sortase A and sortase B in murine arthritis, Microbes Infect., 5, 775, 10.1016/S1286-4579(03)00143-6 · DOI · Paper page
  104. Horsburgh, 2001, In Staphylococcus aureus, Fur is an interactive regulator with PerR, contributes to virulence, and is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis, J. Bacteriol., 183, 468, 10.1128/JB.183.2.468-475.2001 · DOI · Paper page
  105. Johnson, 2011, Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus, Int. J. Med. Microbiol., 301, 44, 10.1016/j.ijmm.2010.05.003 · DOI
  106. Torres, 2010, Staphylococcus aureus Fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia, Infect. Immun., 78, 1618, 10.1128/IAI.01423-09 · DOI · Paper page
  107. Bogos, 2014, Perturbation of iron homeostasis promotes the evolution of antibiotic resistance, Mol. Biol. Evol., 31, 2793, 10.1093/molbev/msu223 · DOI
  108. Allard, 2006, Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo, Microbes Infect., 8, 1679, 10.1016/j.micinf.2006.01.022 · DOI
  109. Lojek, 2018, Fur regulation of Staphylococcus aureus heme oxygenases is required for heme homeostasis, Int. J. Med. Microbiol., 308, 582, 10.1016/j.ijmm.2018.01.009 · DOI
  110. Porcheron, 2015, Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity, Vet. Microbiol., 179, 2, 10.1016/j.vetmic.2015.03.024 · DOI · Paper page
  111. Liu, 2018, Assessment of bona fide sRNAs in Staphylococcus aureus, Front. Microbiol., 9, 1
  112. Mäder, U., Nicolas, P., Depke, M., Pané-Farré, J., Debarbouille, M., van der Kooi-Pol, M.M., Guérin, C., Dérozier, S., Hiron, A., and Jarmer, H. (2016). Staphylococcus aureus transcriptome architecture: From laboratory to infection-mimicking conditions. PLOS Genet., 12. · DOI · Paper page
  113. Shahmirzadi, 2016, Evaluation of Staphylococcus aureus lipoproteins: Role in nutritional acquisition and pathogenicity, Front. Microbiol., 7, 1, 10.3389/fmicb.2016.01404 · DOI
  114. Williams, 2006, Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins, Proc. Natl. Acad. Sci. USA, 103, 13831, 10.1073/pnas.0603072103 · DOI · Paper page
  115. Hashimoto, 2006, Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components, Int. Immunol., 18, 355, 10.1093/intimm/dxh374 · DOI · Paper page
  116. Nguyen, 2017, Intercellular communication for innate immunity, Mol. Immunol., 86, 16, 10.1016/j.molimm.2016.10.002 · DOI
  117. Schmaler, 2009, Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo, J. Immunol., 182, 7110, 10.4049/jimmunol.0804292 · DOI
  118. Recsei, 1986, Regulation of exoprotein gene expression in Staphylococcus aureus by agr, Mol. Gen. Genet. MGG, 202, 58, 10.1007/BF00330517 · DOI · Paper page
  119. Xiong, 2006, Regulation of Staphylococcus aureus α-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis, J. Infect. Dis., 194, 1267, 10.1086/508210 · DOI · Paper page
  120. Novick, 1995, Theagr P2 operon: An autocatalytic sensory transduction system in Staphylococcus aureus, Mol. Gen. Genet. MGG, 248, 446, 10.1007/BF02191645 · DOI · Paper page
  121. Koenig, 2004, Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region, J. Bacteriol., 186, 7549, 10.1128/JB.186.22.7549-7555.2004 · DOI · Paper page
  122. Reyes, 2011, Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus, J. Bacteriol., 193, 6020, 10.1128/JB.05436-11 · DOI · Paper page
  123. Sidote, 2008, Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding, Structure, 16, 727, 10.1016/j.str.2008.02.011 · DOI
  124. Leonard, 2012, Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding, Biochemistry, 51, 10035, 10.1021/bi3011785 · DOI
  125. Bezar, 2019, Drug-like fragments inhibit agr-mediated virulence expression in Staphylococcus aureus, Sci. Rep., 9, 6786, 10.1038/s41598-019-42853-z · DOI
  126. Khodaverdian, 2013, Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 57, 3645, 10.1128/AAC.00269-13 · DOI
  127. Yu, 2014, Combinatorial synthesis and in vitro evaluation of a biaryl hydroxyketone library as antivirulence agents against MRSA, ACS Comb. Sci., 16, 85, 10.1021/co400142t · DOI
  128. Kuo, 2015, Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to β-lactam antibiotics, Antimicrob. Agents Chemother., 59, 1512, 10.1128/AAC.04767-14 · DOI
  129. Greenberg, 2018, Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against gram-positive pathogens, Sci. Rep., 8, 14578, 10.1038/s41598-018-32829-w · DOI
  130. Sully, E.K., Malachowa, N., Elmore, B.O., Alexander, S.M., Femling, J.K., Gray, B.M., DeLeo, F.R., Otto, M., Cheung, A.L., and Edwards, B.S. (2014). Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog., 10. · DOI · Paper page
  131. Figueroa, 2014, Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry, J. Nat. Prod., 77, 1351, 10.1021/np5000704 · DOI
  132. Daly, 2015, ω-Hydroxyemodin limits Staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation, Antimicrob. Agents Chemother., 59, 2223, 10.1128/AAC.04564-14 · DOI
  133. Parlet, 2019, Apicidin attenuates MRSA virulence through quorum-sensing inhibition and enhanced host defense, Cell Rep., 27, 187, 10.1016/j.celrep.2019.03.018 · DOI
  134. Ji, 1997, Bacterial interference caused by autoinducing peptide variants, Science, 276, 2027, 10.1126/science.276.5321.2027 · DOI · Paper page
  135. Mayville, 1999, Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence, Proc. Natl. Acad. Sci. USA, 96, 1218, 10.1073/pnas.96.4.1218 · DOI · Paper page
  136. Stacy, 2013, Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide, J. Am. Chem. Soc., 135, 7869, 10.1021/ja3112115 · DOI
  137. Ivancic, 2013, Structural characterization of native autoinducing peptides and abiotic analogues reveals key features essential for activation and inhibition of an AgrC quorum sensing receptor in Staphylococcus aureus, J. Am. Chem. Soc., 135, 18436, 10.1021/ja407533e · DOI
  138. Vasquez, 2017, Simplified AIP-II peptidomimetics are potent inhibitors of Staphylococcus aureus AgrC quorum sensing receptors, ChemBioChem, 18, 413, 10.1002/cbic.201600516 · DOI
  139. Vasquez, 2019, Simplified autoinducing peptide mimetics with single-nanomolar activity against the Staphylococcus aureus AgrC quorum sensing receptor, ACS Infect. Dis., 5, 484, 10.1021/acsinfecdis.9b00002 · DOI · Paper page
  140. Niu, 2013, Molecular insight into the inhibition mechanism of cyrtominetin to α-hemolysin by molecular dynamics simulation, Eur. J. Med. Chem., 62, 320, 10.1016/j.ejmech.2013.01.008 · DOI
  141. Dong, J., Qiu, J., Zhang, Y., Lu, C., Dai, X., Wang, J., Li, H., Wang, X., Tan, W., and Luo, M. (2013). Oroxylin a inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. PLoS Comput. Biol., 9. · DOI
  142. Qiu, J., Wang, D., Zhang, Y., Dong, J., Wang, J., and Niu, X. (2013). Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. PLoS ONE, 8. · DOI
  143. Qiu, 2013, Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model, J. Infect. Dis., 208, 978, 10.1093/infdis/jit247 · doi:10.1093/infdis/jit247
  144. Rani, 2014, Inhibition of pore formation by blocking the assembly of Staphylococcus aureus α-hemolysin through a novel peptide inhibitor: An in silco approach, Int. J. Pept. Res. Ther., 20, 575, 10.1007/s10989-014-9424-x · DOI
  145. Ragle, 2010, Prevention and treatment of Staphylococcus aureus pneumonia with beta-cyclodextrin derivative, Antimicrob. Agents Chemother., 54, 298, 10.1128/AAC.00973-09 · DOI
  146. Karginov, 2007, Inhibition of S. aureus α-hemolysin and B. anthracis lethal toxin by β-cyclodextrin derivatives, Bioorg. Med. Chem., 15, 5424, 10.1016/j.bmc.2007.05.058 · DOI
  147. McCormick, 2009, Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus, Investig. Ophthalmol. Vis. Sci., 50, 2848, 10.1167/iovs.08-3157 · DOI
  148. Teixeira, 2009, Interaction of heparins and dextran sulfates with a mesoscopic protein nanopore, Biophys. J., 97, 2894, 10.1016/j.bpj.2009.09.019 · DOI
  149. Melo, 2016, Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes, FEMS Microbiol. Lett., 363, fnv207, 10.1093/femsle/fnv207 · doi:10.1093/femsle/fnv207
  150. Kim, 2009, Effect of iron-chelator deferiprone on the in vitro growth of staphylococci, J. Korean Med. Sci., 24, 289, 10.3346/jkms.2009.24.2.289 · DOI
  151. Thompson, 2012, Antibacterial activities of iron chelators against common nosocomial pathogens, Antimicrob. Agents Chemother., 56, 5419, 10.1128/AAC.01197-12 · DOI · Paper page
  152. Richter, 2017, A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity, Antimicrob. Agents Chemother., 61, 1, 10.1128/AAC.00481-17 · DOI
  153. Richter, 2017, Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants, Front. Cell. Infect. Microbiol., 7, 1, 10.3389/fcimb.2017.00280 · DOI
  154. Zhou, 2014, In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin, FEMS Microbiol. Lett., 355, 124, 10.1111/1574-6968.12465 · DOI
  155. Zhou, 2015, Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: Design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains, Eur. J. Med. Chem., 94, 8, 10.1016/j.ejmech.2015.02.050 · DOI
  156. Ang, 2018, DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity, Medchemcomm, 9, 1206, 10.1039/C8MD00192H · DOI
  157. Li, 2016, Macromolecular iron-chelators via RAFT-polymerization for the inhibition of methicillin-resistant Staphylococcus aureus growth, Polymer (Guildf)., 87, 64, 10.1016/j.polymer.2016.01.073 · DOI
  158. Savage, 2018, Novel iron-chelator DIBI inhibits Staphylococcus aureus growth, suppresses experimental MRSA infection in mice and enhances the activities of diverse antibiotics in vitro, Front. Microbiol., 9, 1811, 10.3389/fmicb.2018.01811 · DOI
  159. Workman, 2016, Synthesis of novel iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents, J. Inorg. Biochem., 160, 49, 10.1016/j.jinorgbio.2016.04.018 · DOI
  160. Braun, 2009, Sideromycins: Tools and antibiotics, BioMetals, 22, 3, 10.1007/s10534-008-9199-7 · DOI · Paper page
  161. Sloderbach, 2014, Siderophore–drug complexes: Potential medicinal applications of the ‘Trojan horse’ strategy, Trends Pharmacol. Sci., 35, 442, 10.1016/j.tips.2014.06.007 · DOI · Paper page
  162. Heinisch, 2009, Siderophores as drug delivery agents: Application of the “Trojan Horse” strategy, BioMetals, 22, 615, 10.1007/s10534-009-9219-2 · DOI · Paper page
  163. Reynolds, 1947, Grisein, a new antibiotic produced by a strain of Streptomyces griseus, Exp. Biol. Med., 64, 50, 10.3181/00379727-64-15695 · DOI
  164. Benz, 1982, Constitution of the deferriform of the albomycins δ1, δ2, and ε, Angew. Chemie Int. Ed. English, 21, 527, 10.1002/anie.198205271 · DOI
  165. Gause, 1955, Recent studies on albomycin, a new antibiotic, Br. Med. J., 2, 1177, 10.1136/bmj.2.4949.1177 · DOI
  166. Aretz, 1995, Salmycin A-D, antibiotika aus Streptomyces violaceus, DSM 8286, mit siderophor-aminoglycosid-struktur, Helv. Chim. Acta, 78, 46, 10.1002/hlca.19950780105 · DOI
  167. Bunet, 2006, Identification of genes involved in siderophore transport in Streptomyces coelicolor A3(2), FEMS Microbiol. Lett., 262, 57, 10.1111/j.1574-6968.2006.00362.x · DOI
  168. Ballouche, 2009, Iron metabolism: A promising target for antibacterial strategies, Recent Pat. Antiinfect. Drug Discov., 4, 190, 10.2174/157489109789318514 · DOI
  169. Wencewicz, 2013, Trihydroxamate siderophore–fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus, Bioconjug. Chem., 24, 473, 10.1021/bc300610f · DOI
  170. Braun, 1999, Active transport of siderophore-mimicking antibacterials across the outer membrane, Drug Resist. Updat., 2, 363, 10.1054/drup.1999.0107 · DOI
  171. Pugsley, 1987, Highly efficient uptake of a rifamycin derivative via the FhuA-TonB-dependent uptake route in Escherichia coli, Microbiology, 133, 3505, 10.1099/00221287-133-12-3505 · DOI
  172. Negash, K.H., Norris, J.K.S., and Hodgkinson, J.T. (2019). Siderophore–antibiotic conjugate design: New drugs for bad bugs?. Molecules, 24. · DOI
  173. Neumann, 2018, Esterase-catalyzed siderophore hydrolysis activates an enterobactin–ciprofloxacin conjugate and confers targeted antibacterial activity, J. Am. Chem. Soc., 140, 5193, 10.1021/jacs.8b01042 · DOI
  174. Lin, 2019, Synthetic sideromycins (skepticism and optimism): Selective generation of either broad or narrow spectrum gram-negative antibiotics, BioMetals, 32, 425, 10.1007/s10534-019-00192-6 · DOI
  175. Kong, 2019, An overview of recent progress in siderophore-antibiotic conjugates, Eur. J. Med. Chem., 182, 111615, 10.1016/j.ejmech.2019.111615 · DOI
  176. Zähner, H., Diddens, H., Keller-Schierlein, W., and Nägeli, H.U. (1977). Some experiments with semisynthetic sideromycins. Jpn. J. Antibiot., 201–206. Available online: https://europepmc.org/article/med/612705.
  177. Ghosh, 1996, Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates, Bioorganic Med. Chem., 4, 43, 10.1016/0968-0896(95)00161-1 · DOI
  178. Ghosh, 1995, Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: Iron transport-mediated drug delivery, Bioorg. Med. Chem., 3, 1519, 10.1016/0968-0896(95)00134-3 · DOI
  179. Milner, 2013, Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics, Org. Biomol. Chem., 11, 3461, 10.1039/c3ob40162f · DOI
  180. Ji, 2012, Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers, Bioorg. Med. Chem., 20, 3828, 10.1016/j.bmc.2012.04.034 · DOI
  181. Ji, 2015, Siderophore–fluoroquinolone conjugates containing potential reduction-triggered linkers for drug release: Synthesis and antibacterial activity, BioMetals, 28, 541, 10.1007/s10534-015-9830-3 · DOI
  182. DeLeon, 2009, Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice, Antimicrob. Agents Chemother., 53, 1331, 10.1128/AAC.01330-08 · DOI
  183. Bonchi, 2014, Repurposing of gallium-based drugs for antibacterial therapy, BioFactors, 40, 303, 10.1002/biof.1159 · DOI
  184. Bernstein, 2015, Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections, Front. Microbiol., 6, 1
  185. Baldoni, 2010, In vitro activity of gallium maltolate against staphylococci in logarithmic, stationary, and biofilm growth phases: Comparison of conventional and calorimetric susceptibility testing methods, Antimicrob. Agents Chemother., 54, 157, 10.1128/AAC.00700-09 · DOI
  186. Kelson, 2013, Gallium-based anti-infectives: Targeting microbial iron-uptake mechanisms, Curr. Opin. Pharmacol., 13, 707, 10.1016/j.coph.2013.07.001 · DOI · Paper page
  187. Bernstein, 1998, Mechanisms of therapeutic activity for gallium, Pharmacol. Rev., 50, 665
  188. Emery, 1986, Exchange of iron by gallium in siderophores, Biochemistry, 25, 4629, 10.1021/bi00364a026 · DOI
  189. Kaneko, 2007, The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity, J. Clin. Investig., 117, 877, 10.1172/JCI30783 · DOI · Paper page
  190. Richter, 2017, Innovative approaches to treat Staphylococcus aureus biofilm-related infections, Essays Biochem., 61, 61, 10.1042/EBC20160056 · DOI
  191. Minandri, 2014, Promises and failures of gallium as an antibacterial agent, Future Microbiol., 9, 379, 10.2217/fmb.14.3 · DOI
  192. Bernstein, 2000, Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability, Met. Based. Drugs, 7, 33, 10.1155/MBD.2000.33 · DOI · Paper page
  193. Rodriguez, 2008, Utilization of Fe3+-acinetoferrin analogs as an iron source by Mycobacterium tuberculosis, BioMetals, 21, 93, 10.1007/s10534-007-9096-5 · DOI
  194. Richter, 2016, Mind “De GaPP”: In vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms, Int. Forum Allergy Rhinol., 6, 737, 10.1002/alr.21735 · DOI
  195. Chang, D., Garcia, R., Akers, K., Mende, K., Murray, C., Wenke, J., and Sanchez Jr., C. (2016). J. Activity of gallium meso- and protoporphyrin IX against biofilms of multidrug-resistant Acinetobacter baumannii isolates. Pharmaceuticals, 9. · DOI
  196. Grunenwald, 2018, Nonconventional therapeutics against Staphylococcus aureus, Microbiol. Spectr., 6, 776, 10.1128/microbiolspec.GPP3-0047-2018 · DOI
  197. Thompson, 2015, Evaluation of gallium citrate formulations against a multidrug-resistant strain of Klebsiella pneumoniae in a murine wound model of infection, Antimicrob. Agents Chemother., 59, 6484, 10.1128/AAC.00882-15 · DOI
  198. Hijazi, 2017, Gallium-protoporphyrin IX inhibits Pseudomonas aeruginosa growth by targeting cytochromes, Front. Cell. Infect. Microbiol., 7, 1, 10.3389/fcimb.2017.00012 · DOI
  199. Ramos, 2019, Antimicrobial activity and safety applications of meso-tetra(4-pyridyl)platinum(II) porphyrin, Microb. Pathog., 128, 47, 10.1016/j.micpath.2018.12.038 · DOI
  200. Managa, 2015, Photodynamic antimicrobial chemotherapy activity of gallium tetra-(4-carboxyphenyl) porphyrin when conjugated to differently shaped platinum nanoparticles, J. Mol. Struct., 1099, 432, 10.1016/j.molstruc.2015.06.077 · DOI

200 of 232 shown

Cited by

See all 97

Metadata

Authors
Marchetti, M., De Bei, O., Bettati, S., Campanini, B., Kovachka, S., Gianquinto, E., Spyrakis, F., & Ronda, L.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-03-20
Volume
21
Issue
6
Pages
2145
ISSN
1422-0067
Cited by
97
References
95
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development. https://app.cochat.ai/papers/10.3390/ijms21062145
The paper
Marchetti, M., De Bei, O., Bettati, S., Campanini, B., Kovachka, S., Gianquinto, E., Spyrakis, F., & Ronda, L. (2020). Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21062145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.